AG
ABBV icon

AIA Group’s AbbVie ABBV Stock Holding History

AIA Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$16.2M Buy
74,580
+14,163
+23% +$3.14M 0.24% 65
2025
Q4 		$13.8M Buy
60,417
+33,580
+125% +$7.65M 0.21% 73
2025
Q3 		$6.21M Buy
26,837
+15,295
+133% +$3.11M 0.11% 123
2025
Q2 		$2.14M Sell
11,542
-12,286
-52% -$2.28M 0.05% 169
2025
Q1 		$4.99M Sell
23,828
-786
-3% -$153K 0.12% 91
2024
Q4 		$4.37M Sell
24,614
-12,459
-34% -$2.29M 0.11% 92
2024
Q3 		$7.32M Sell
37,073
-10,861
-23% -$2.03M 0.19% 62
2024
Q2 		$8.22M Buy
47,934
+3,939
+9% +$652K 0.24% 51
2024
Q1 		$8.01M Buy
43,995
+32,295
+276% +$5.57M 0.26% 43
2023
Q4 		$1.81M Buy
11,700
+3,499
+43% +$510K 0.07% 131
2023
Q3 		$1.22M Buy
+8,201
New +$1.2M 0.06% 150
2023
Q2 		– Sell
-28,131
Closed -$4.48M – 320
2023
Q1 		$4.48M Sell
28,131
-3,951
-12% -$604K 0.24% 40
2022
Q4 		$5.18M Buy
32,082
+15,249
+91% +$2.34M 0.32% 35
2022
Q3 		$2.26M Sell
16,833
-16,569
-50% -$2.38M 0.15% 62
2022
Q2 		$5.12M Buy
33,402
+5,699
+21% +$871K 0.27% 45
2022
Q1 		$4.49M Sell
27,703
-1,630
-6% -$237K 0.2% 49
2021
Q4 		$3.97M Buy
29,333
+21,791
+289% +$2.57M 0.19% 63
2021
Q3 		$814K Sell
7,542
-6,733
-47% -$769K 0.05% 151
2021
Q2 		$1.65M Buy
14,275
+3,396
+31% +$382K 0.11% 89
2021
Q1 		$1.18M Buy
10,879
+4,474
+70% +$479K 0.17% 81
2020
Q4 		$685K Buy
+6,405
New +$616K 0.08% 100

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AIA Group's ABBV Position: Q1 2026 in Review

AIA Group increased its AbbVie (ABBV) stake by 23% in Q1 2026, buying an estimated $3.14M and bringing the position to 74,580 shares worth $16.2M. The position accounts for 0.24% of the portfolio, ranked #65.

AIA Group first reported a position in ABBV in Q4 2020 and has held it in 21 quarters since. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • AIA Group held 74,580 shares of AbbVie worth $16.2M as of Q1 2026.
  • AIA Group bought 14,163 AbbVie shares in Q1 2026, an estimated $3.14M.
  • AbbVie made up 0.24% of AIA Group's portfolio in Q1 2026, its #65 holding.
  • AIA Group first reported a position in AbbVie in Q4 2020 and has held it in 21 quarters since.
  • 4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on AIA Group's 13F filing for Q1 2026, filed 6 May 2026.